|
BL-M05D1 Clinical Trials
2 actively recruiting trials across 1 location
Pipeline
Phase 1: 2
Top Sponsors
- SystImmune Inc.1
- Sichuan Baili Pharmaceutical Co., Ltd.1
Indications
- Cancer2
- Advanced Pancreatic Ductal Adenocarcinoma1
- Other Solid Tumors1
- Gastric Adenocarcinoma1
- Locally Advanced or Metastatic Solid Tumors1
Other1 trial
Phoenix, Arizona1 trial
Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors
Mayo Clinic Cancer Center- Phoenix
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.